An Overview of Nanoparticle Protein Corona Literature
المؤلف | Hajipour, Mohammad J. |
المؤلف | Safavi-Sohi, Reihaneh |
المؤلف | Sharifi, Shahriar |
المؤلف | Mahmoud, Nouf |
المؤلف | Ashkarran, Ali Akbar |
المؤلف | Voke, Elizabeth |
المؤلف | Serpooshan, Vahid |
المؤلف | Ramezankhani, Milad |
المؤلف | Milani, Abbas S. |
المؤلف | Landry, Markita P. |
المؤلف | Mahmoudi, Morteza |
تاريخ الإتاحة | 2023-06-19T10:24:47Z |
تاريخ النشر | 2023-04-29 |
اسم المنشور | Small |
المعرّف | http://dx.doi.org/10.1002/smll.202301838 |
الاقتباس | Hajipour, M. J., Safavi‐Sohi, R., Sharifi, S., Mahmoud, N., Ashkarran, A. A., Voke, E., ... & Mahmoudi, M. (2023). An Overview of Nanoparticle Protein Corona Literature. Small, 2301838. |
الرقم المعياري الدولي للكتاب | 1613-6810 |
الملخص | The protein corona forms spontaneously on nanoparticle surfaces when nanomaterials are introduced into any biological system/fluid. Reliable characterization of the protein corona is, therefore, a vital step in the development of safe and efficient diagnostic and therapeutic nanomedicine products. 2134 published manuscripts on the protein corona are reviewed and a down-selection of 470 papers spanning 2000–2021, comprising 1702 nanoparticle (NP) systems is analyzed. This analysis reveals: i) most corona studies have been conducted on metal and metal oxide nanoparticles; ii) despite their overwhelming presence in clinical practice, lipid-based NPs are underrepresented in protein corona research, iii) studies use new methods to improve reliability and reproducibility in protein corona research; iv) studies use more specific protein sources toward personalized medicine; and v) careful characterization of nanoparticles after corona formation is imperative to minimize the role of aggregation and protein contamination on corona outcomes. As nanoparticles used in biomedicine become increasingly prevalent and biochemically complex, the field of protein corona research will need to focus on developing analytical approaches and characterization techniques appropriate for each unique nanoparticle formulation. Achieving such characterization of the nano-bio interface of nanobiotechnologies will enable more seamless development and safe implementation of nanoparticles in medicine. |
راعي المشروع | This project is supported by the US National Institute of Diabetes and Digestive and Kidney Diseases (grant DK131417) (to M.M.). |
اللغة | en |
الناشر | Wiley-Blackwell |
الموضوع | analytical chemistry characterization nanomedicine protein corona reproducibility standard procedures |
النوع | Article |
ESSN | 1613-6829 |
الملفات في هذه التسجيلة
هذه التسجيلة تظهر في المجموعات التالية
-
العلوم الحيوية الطبية [738 items ]